Clinical Research Web
Clinical Research
Overview
Application Process
Researchers Toolkit
| Policies and Guidelines |
Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities
Grant Mechanisms
Office of Training &
Career Development
Contracts Management
Review Committees
Funding News
Program Areas
NINDS is part of the
National Institutes of
Health
The NINDS Terms of Award for Clinical Research will apply to all grants that involve human subjects and that are perceived by the NINDS to pose a greater than minimal risk to participants. (Minimal Risk: A risk is minimal where the probability and magnitude of harm or discomfort anticipated in the proposed research are not greater, in and of themselves, than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests. For example, the risk of drawing a small amount of blood from a healthy individual for research purposes is no greater than the risk of doing so as part of routine physical examination).
The final version of the study protocol should be submitted to the NINDS program official prior to the start of study enrollment.
Notification of any of the above changes must be made within three (3) working days by e-mail, followed by a letter from the Principal Investigator, detailing the change of status notification to the local IRB/EC and a copy of any responses from the IRB/EC.
Last updated April 20, 2007